🇺🇸 FDA
Pipeline program

Selatogrel solution matching placebo, Selatogrel solution

ID-076A301

Phase 3 small_molecule active

Quick answer

Selatogrel solution matching placebo, Selatogrel solution for Acute myocardial infarction (AMI) is a Phase 3 program (small_molecule) at Viatris Pharmaceuticals Co., with 1 ClinicalTrials.gov record(s).

Program details

Company
Viatris Pharmaceuticals Co.,
Indication
Acute myocardial infarction (AMI)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials